FKTN

fukutin

Basic information

Region (hg38): 9:105558122-105653820

Previous symbols: [ "FCMD" ]

Links

ENSG00000106692NCBI:2218OMIM:607440HGNC:3622Uniprot:O75072AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal recessive limb-girdle muscular dystrophy type 2M (Definitive), mode of inheritance: AR
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 (Strong), mode of inheritance: AR
  • dilated cardiomyopathy 1X (Limited), mode of inheritance: AR
  • familial isolated dilated cardiomyopathy (Supportive), mode of inheritance: AD
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 (Supportive), mode of inheritance: AR
  • muscular dystrophy-dystroglycanopathy, type A (Supportive), mode of inheritance: AR
  • muscle-eye-brain disease (Supportive), mode of inheritance: AR
  • autosomal recessive limb-girdle muscular dystrophy type 2M (Supportive), mode of inheritance: AR
  • congenital muscular dystrophy without intellectual disability (Supportive), mode of inheritance: AR
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 (Definitive), mode of inheritance: AR
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 (Strong), mode of inheritance: AR
  • autosomal recessive limb-girdle muscular dystrophy type 2M (Strong), mode of inheritance: AR
  • myopathy caused by variation in FKTN (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cardiomyopathy, dilated, 1X; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4; Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4ARCardiovascular; MusculoskeletalSurveillance for cardiovascular complications may allow early diagnosis and treatment, which may ameliorate morbidity and mortality; Cardiomyopathy, dilated, 1X has been reported as being treated with transplant; Individuals with Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4 has been reported as benefiting from treatment with steroidsCardiovascular; Musculoskeletal; Neurologic; Ophthalmologic7258547; 8124873; 9690476; 10545611; 10817652; 12601708; 17036286; 17044012; 17878207; 18177472; 19015585; 19342235; 19299310; 19179078; 19842201; 20627570; 20961758

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FKTN gene.

  • Walker-Warburg_congenital_muscular_dystrophy (723 variants)
  • Cardiovascular_phenotype (265 variants)
  • not_provided (223 variants)
  • Dilated_cardiomyopathy_1X (145 variants)
  • Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),_type_A,_4 (144 variants)
  • Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2M (99 variants)
  • Muscular_dystrophy-dystroglycanopathy_(congenital_without_intellectual_disability),_type_B4 (96 variants)
  • not_specified (76 variants)
  • Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),_type_A1 (40 variants)
  • FKTN-related_disorder (21 variants)
  • Cardiomyopathy (4 variants)
  • See_cases (3 variants)
  • Myopathy_caused_by_variation_in_FKTN (3 variants)
  • Hypertrophic_cardiomyopathy (2 variants)
  • Dilated_Cardiomyopathy,_Recessive (2 variants)
  • Global_developmental_delay (1 variants)
  • Ventricular_tachycardia (1 variants)
  • Primary_dilated_cardiomyopathy (1 variants)
  • Primary_familial_dilated_cardiomyopathy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FKTN gene is commonly pathogenic or not. These statistics are base on transcript: NM_001079802.2. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
5
clinvar
201
clinvar
1
clinvar
209
missense
2
clinvar
24
clinvar
349
clinvar
13
clinvar
1
clinvar
389
nonsense
23
clinvar
25
clinvar
48
start loss
1
1
2
frameshift
29
clinvar
48
clinvar
7
clinvar
84
splice donor/acceptor (+/-2bp)
1
clinvar
27
clinvar
4
clinvar
1
clinvar
33
Total 55 127 366 215 2

Highest pathogenic variant AF is 0.000183708

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FKTNprotein_codingprotein_codingENST00000223528 982989
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
8.66e-70.98212556901791257480.000712
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.04662392371.010.00001233051
Missense in Polyphen6062.5210.95968808
Synonymous1.247286.70.8300.00000461836
Loss of Function2.181426.00.5380.00000141299

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001580.00158
Ashkenazi Jewish0.007850.00787
East Asian0.0003810.000381
Finnish0.00004620.0000462
European (Non-Finnish)0.0002290.000229
Middle Eastern0.0003810.000381
South Asian0.0004250.000425
Other0.0006560.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Glycosyltransferase involved in the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine- beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1). Required for normal location of POMGNT1 in Golgi membranes, and for normal POMGNT1 activity (PubMed:17034757). May interact with and reinforce a large complex encompassing the outside and inside of muscle membranes. Could be involved in brain development. {ECO:0000269|PubMed:17034757, ECO:0000269|PubMed:25279699}.;
Disease
DISEASE: Muscular dystrophy-dystroglycanopathy congenital without mental retardation B4 (MDDGB4) [MIM:613152]: An autosomal recessive disorder characterized by congenital muscular dystrophy and evidence of dystroglycanopathy. Features included increased serum creatine kinase, generalized weakness, mild white matter changes on brain MRI, and absence of mental retardation. {ECO:0000269|PubMed:14627679, ECO:0000269|PubMed:18177472, ECO:0000269|PubMed:19179078, ECO:0000269|PubMed:19299310}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Muscular dystrophy-dystroglycanopathy limb-girdle C4 (MDDGC4) [MIM:611588]: An autosomal recessive degenerative myopathy characterized by progressive weakness of the pelvic and shoulder girdle muscles, and elevated serum creatine kinase. MDDGC4 has no brain involvement and a remarkable clinical response to corticosteroids. {ECO:0000269|PubMed:17044012, ECO:0000269|PubMed:19342235}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1X (CMD1X) [MIM:611615]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:17036286}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Mannose type O-glycan biosynthesis - Homo sapiens (human) (Consensus)

Recessive Scores

pRec
0.389

Intolerance Scores

loftool
0.322
rvis_EVS
0.58
rvis_percentile_EVS
82.25

Haploinsufficiency Scores

pHI
0.0950
hipred
N
hipred_score
0.348
ghis
0.521

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.479

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fktn
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; growth/size/body region phenotype; muscle phenotype;

Zebrafish Information Network

Gene name
fktn
Affected structure
ocular blood vessel
Phenotype tag
abnormal
Phenotype quality
deformed

Gene ontology

Biological process
protein O-linked glycosylation;nervous system development;muscle organ development;negative regulation of cell population proliferation;protein O-linked mannosylation;negative regulation of JNK cascade;regulation of protein glycosylation
Cellular component
extracellular space;nucleus;endoplasmic reticulum;Golgi apparatus;cis-Golgi network;integral component of Golgi membrane
Molecular function
protein binding;transferase activity